{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,21]],"date-time":"2026-07-21T09:45:55Z","timestamp":1784627155244,"version":"3.55.0"},"reference-count":26,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2023,7,14]],"date-time":"2023-07-14T00:00:00Z","timestamp":1689292800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2023,7,14]],"date-time":"2023-07-14T00:00:00Z","timestamp":1689292800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"name":"funding from Jiangxi Provincial Key Laboratory of Birth Defect for Prevention and Control","award":["no"],"award-info":[{"award-number":["no"]}]},{"name":"Project of Jiangxi Provincial Department of Education","award":["GJJ211555"],"award-info":[{"award-number":["GJJ211555"]}]},{"name":"Science and Technology Plan of Health Commission of Jiangxi Province","award":["202310848"],"award-info":[{"award-number":["202310848"]}]},{"name":"the Creative Research Groups of Gannan Medical University","award":["TD201704"],"award-info":[{"award-number":["TD201704"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Mol Cytogenet"],"abstract":"<jats:title>Abstract<\/jats:title><jats:sec>\n                <jats:title>Background<\/jats:title>\n                <jats:p>Non-invasive prenatal testing (NIPT) using cell-free DNA has been widely used for prenatal screening to detect the common fetal aneuploidies (such as trisomy 21, 18, and 13). NIPT has been shown to be highly sensitive and specific in previous studies, but false positives (FPs) and false negatives (FNs) occur. Although the prevalence of FN NIPT results for Down syndrome is rare, the impact on families and society is significant.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Case presentation<\/jats:title>\n                <jats:p>This article described two cases of foetuses that tested \u201cnegative\u201d for trisomy 21 by NIPT technology using the semiconductor sequencing platform. However, the fetal karyotypes of amniotic fluid were 46,XY,\u2009+\u200921 der(21;21)(q10;q10) and 47,XY,\u2009+\u200921 karyotypes, respectively. Placental biopsies confirmed that, in the first case, the chromosome 21 placenta chimerism ratio ranged from 13 to 88% with the 46,XX,\u2009+\u200921,der(21;21)(q10;q10)[86]\/46,XX[14] karyotype of placental chorionic cells (middle of fetal-side placental tissue). However, in the second case, of all the placental biopsies, percentage of total chimerism was less than 30%; and placental biopsies taken at the middle of maternal side and middle of fetal side, also had variable trisomy 2 mosaicism levels of 10% and 8%, respectively. Ultimately, the pregnancies were interrupted at 30 gestational age (GA) and 27GA, respectively.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Conclusions<\/jats:title>\n                <jats:p>In this study, we present two cases of FN NIPT results that might have been caused by biological mechanisms, as opposed to poor quality, technical errors, or negligence. Clinical geneticists and their patients must understand that NIPT is a screening procedure.<\/jats:p>\n              <\/jats:sec>","DOI":"10.1186\/s13039-023-00643-3","type":"journal-article","created":{"date-parts":[[2023,7,14]],"date-time":"2023-07-14T08:02:26Z","timestamp":1689321746000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":6,"title":["Two cases of placental trisomy 21 mosaicism causing false-negative NIPT results"],"prefix":"10.1186","volume":"16","author":[{"given":"Qinfei","family":"Zhao","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jing","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ling","family":"Ren","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Huijuan","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dedong","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xuxiang","family":"Xi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiangsheng","family":"Wu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chunyun","family":"Fang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ping","family":"Ye","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shaoying","family":"Zeng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tianyu","family":"Zhong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2023,7,14]]},"reference":[{"issue":"1","key":"643_CR1","doi-asserted-by":"publisher","first-page":"15","DOI":"10.1016\/j.jpeds.2007.09.045","volume":"152","author":"ME Weijerman","year":"2008","unstructured":"Weijerman ME, van Furth AM, Vonk Noordegraaf A, van Wouwe JP, Broers CJ, Gemke RJ. Prevalence, neonatal characteristics, and first-year mortality of Down syndrome: a national study. J Pediatr. 2008;152(1):15\u20139.","journal-title":"J Pediatr"},{"issue":"6","key":"643_CR2","doi-asserted-by":"publisher","first-page":"591","DOI":"10.1001\/jama.2018.9418","volume":"320","author":"MA Allyse","year":"2018","unstructured":"Allyse MA, Wick MJ. Noninvasive prenatal genetic screening using cell-free DNA. JAMA. 2018;320(6):591\u20132.","journal-title":"JAMA"},{"issue":"1","key":"643_CR3","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1111\/cge.13155","volume":"94","author":"L Nshimyumukiza","year":"2018","unstructured":"Nshimyumukiza L, Menon S, Hina H, Rousseau F, Reinharz D. Cell-free DNA noninvasive prenatal screening for aneuploidy versus conventional screening. A systematic review of economic evaluations. Clin Genet. 2018;94(1):3\u201321.","journal-title":"Clin Genet"},{"issue":"13","key":"643_CR4","doi-asserted-by":"publisher","first-page":"1233","DOI":"10.1002\/pd.3993","volume":"32","author":"B Zimmermann","year":"2012","unstructured":"Zimmermann B, Hill M, Gemelos G, Demko Z, Banjevic M, Baner J, et al. Noninvasive prenatal aneuploidy testing of chromosomes 13, 18, 21, X, and Y, using targeted sequencing of polymorphic loci. Prenat Diagn. 2012;32(13):1233\u201341.","journal-title":"Prenat Diagn"},{"issue":"9","key":"643_CR5","doi-asserted-by":"publisher","first-page":"799","DOI":"10.1056\/NEJMoa1311037","volume":"370","author":"DW Bianchi","year":"2014","unstructured":"Bianchi DW, Parker RL, Wentworth J, Madankumar R, Saffer C, Das AF, et al. DNA sequencing versus standard prenatal aneuploidy screening. N Engl J Med. 2014;370(9):799\u2013808.","journal-title":"N Engl J Med"},{"issue":"17","key":"643_CR6","doi-asserted-by":"publisher","first-page":"1589","DOI":"10.1056\/NEJMoa1407349","volume":"372","author":"ME Norton","year":"2015","unstructured":"Norton ME, Jacobsson B, Swamy GK, Laurent LC, Ranzini AC, Brar H, et al. Cell-free DNA analysis for noninvasive examination of trisomy. N Engl J Med. 2015;372(17):1589\u201397.","journal-title":"N Engl J Med"},{"issue":"3","key":"643_CR7","doi-asserted-by":"publisher","first-page":"302","DOI":"10.1002\/uog.17484","volume":"50","author":"MM Gil","year":"2017","unstructured":"Gil MM, Accurti V, Santacruz B, Plana MN, Nicolaides KH. Analysis of cell-free DNA in maternal blood in screening for aneuploidies: updated meta-analysis. Ultrasound Obstet Gynecol. 2017;50(3):302\u201314.","journal-title":"Ultrasound Obstet Gynecol"},{"issue":"Suppl 1","key":"643_CR8","doi-asserted-by":"publisher","first-page":"S19","DOI":"10.1517\/14712598.2012.670632","volume":"12","author":"BH Faas","year":"2012","unstructured":"Faas BH, de Ligt J, Janssen I, Eggink AJ, Wijnberger LD, van Vugt JM, et al. Non-invasive prenatal diagnosis of fetal aneuploidies using massively parallel sequencing-by-ligation and evidence that cell-free fetal DNA in the maternal plasma originates from cytotrophoblastic cells. Expert Opin Biol Ther. 2012;12(Suppl 1):S19-26.","journal-title":"Expert Opin Biol Ther"},{"issue":"12","key":"643_CR9","doi-asserted-by":"publisher","first-page":"1207","DOI":"10.1002\/pd.4212","volume":"33","author":"Y Wang","year":"2013","unstructured":"Wang Y, Zhu J, Chen Y, Lu S, Chen B, Zhao X, et al. Two cases of placental T21 mosaicism: challenging the detection limits of non-invasive prenatal testing. Prenat Diagn. 2013;33(12):1207\u201310.","journal-title":"Prenat Diagn"},{"issue":"8","key":"643_CR10","doi-asserted-by":"publisher","first-page":"620","DOI":"10.1038\/gim.2014.3","volume":"16","author":"FR Grati","year":"2014","unstructured":"Grati FR, Malvestiti F, Ferreira JC, Bajaj K, Gaetani E, Agrati C, et al. Fetoplacental mosaicism: potential implications for false-positive and false-negative noninvasive prenatal screening results. Genet Med. 2014;16(8):620\u20134.","journal-title":"Genet Med"},{"key":"643_CR11","doi-asserted-by":"publisher","first-page":"260","DOI":"10.1186\/s12967-015-0569-y","volume":"13","author":"RV Lebo","year":"2015","unstructured":"Lebo RV, Novak RW, Wolfe K, Michelson M, Robinson H, Mancuso MS. Discordant circulating fetal DNA and subsequent cytogenetics reveal false negative, placental mosaic, and fetal mosaic cfDNA genotypes. J Transl Med. 2015;13:260.","journal-title":"J Transl Med"},{"issue":"1","key":"643_CR12","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0146794","volume":"11","author":"D Van Opstal","year":"2016","unstructured":"Van Opstal D, Srebniak MI, Polak J, de Vries F, Govaerts LC, Joosten M, et al. False negative NIPT results: risk figures for chromosomes 13, 18 and 21 based on chorionic villi results in 5967 cases and literature review. PLoS ONE. 2016;11(1): e0146794.","journal-title":"PLoS ONE"},{"issue":"3","key":"643_CR13","doi-asserted-by":"publisher","first-page":"254","DOI":"10.1002\/uog.13277","volume":"43","author":"TK Lau","year":"2014","unstructured":"Lau TK, Cheung SW, Lo PS, Pursley AN, Chan MK, Jiang F, et al. Non-invasive prenatal testing for fetal chromosomal abnormalities by low-coverage whole-genome sequencing of maternal plasma DNA: review of 1982 consecutive cases in a single center. Ultrasound Obstet Gynecol. 2014;43(3):254\u201364.","journal-title":"Ultrasound Obstet Gynecol"},{"issue":"7","key":"643_CR14","doi-asserted-by":"publisher","first-page":"626","DOI":"10.1089\/dna.2017.4112","volume":"37","author":"YH Cai","year":"2018","unstructured":"Cai YH, Yao GY, Chen LJ, Gan HY, Ye CS, Yang XX. The combining effects of cell-free circulating tumor DNA of breast tumor to the noninvasive prenatal testing results. A simulating investigation. DNA Cell Biol. 2018;37(7):626\u201333.","journal-title":"DNA Cell Biol"},{"issue":"5","key":"643_CR15","doi-asserted-by":"publisher","first-page":"527.e521","DOI":"10.1016\/j.ajog.2014.08.006","volume":"211","author":"P Dar","year":"2014","unstructured":"Dar P, Curnow KJ, Gross SJ, Hall MP, Stosic M, Demko Z, et al. Clinical experience and follow-up with large scale single-nucleotide polymorphism-based noninvasive prenatal aneuploidy testing. Am J Obstet Gynecol. 2014;211(5):527.e521-7.e517.","journal-title":"Am J Obstet Gynecol"},{"issue":"5","key":"643_CR16","doi-asserted-by":"publisher","first-page":"530","DOI":"10.1002\/uog.14792","volume":"45","author":"H Zhang","year":"2015","unstructured":"Zhang H, Gao Y, Jiang F, Fu M, Yuan Y, Guo Y, et al. Non-invasive prenatal testing for trisomies 21, 18 and 13: clinical experience from 146,958 pregnancies. Ultrasound Obstet Gynecol. 2015;45(5):530\u20138.","journal-title":"Ultrasound Obstet Gynecol"},{"issue":"6","key":"643_CR17","doi-asserted-by":"publisher","first-page":"527","DOI":"10.1002\/pd.5049","volume":"37","author":"TS Hartwig","year":"2017","unstructured":"Hartwig TS, Ambye L, S\u00f8rensen S, J\u00f8rgensen FS. Discordant non-invasive prenatal testing (NIPT) - a systematic review. Prenat Diagn. 2017;37(6):527\u201339.","journal-title":"Prenat Diagn"},{"issue":"47","key":"643_CR18","doi-asserted-by":"publisher","first-page":"14670","DOI":"10.1073\/pnas.1518151112","volume":"112","author":"AH Yin","year":"2015","unstructured":"Yin AH, Peng CF, Zhao X, Caughey BA, Yang JX, Liu J, et al. Noninvasive detection of fetal subchromosomal abnormalities by semiconductor sequencing of maternal plasma DNA. Proc Natl Acad Sci USA. 2015;112(47):14670\u20135.","journal-title":"Proc Natl Acad Sci USA"},{"key":"643_CR19","doi-asserted-by":"publisher","first-page":"1063480","DOI":"10.3389\/fmed.2022.1063480","volume":"9","author":"KM Kang","year":"2022","unstructured":"Kang KM, Kim SH, Park JE, Kim H, Jang HY, Go M, et al. Inconsistency between non-invasive prenatal testing (NIPT) and conventional prenatal diagnosis due to confined placental and fetal mosaicism: two case reports. Front Med. 2022;9:1063480.","journal-title":"Front Med"},{"key":"643_CR20","doi-asserted-by":"publisher","first-page":"44","DOI":"10.1016\/j.cca.2013.10.007","volume":"428","author":"GJ Liao","year":"2014","unstructured":"Liao GJ, Gronowski AM, Zhao Z. Non-invasive prenatal testing using cell-free fetal DNA in maternal circulation. Clin Chim Acta. 2014;428:44\u201350.","journal-title":"Clin Chim Acta"},{"issue":"2","key":"643_CR21","doi-asserted-by":"publisher","first-page":"177","DOI":"10.1016\/S1701-2163(15)31025-2","volume":"35","author":"S Langlois","year":"2013","unstructured":"Langlois S, Brock JA. RETIRED: current status in non-invasive prenatal detection of Down syndrome, trisomy 18, and trisomy 13 using cell-free DNA in maternal plasma. J Obstet Gynaecol Can. 2013;35(2):177\u201381.","journal-title":"J Obstet Gynaecol Can"},{"issue":"5","key":"643_CR22","doi-asserted-by":"publisher","first-page":"391","DOI":"10.1002\/pd.4804","volume":"36","author":"Y Yaron","year":"2016","unstructured":"Yaron Y. The implications of non-invasive prenatal testing failures: a review of an under-discussed phenomenon. Prenat Diagn. 2016;36(5):391\u20136.","journal-title":"Prenat Diagn"},{"issue":"3","key":"643_CR23","doi-asserted-by":"publisher","first-page":"723","DOI":"10.1093\/humrep\/deh117","volume":"19","author":"E Flori","year":"2004","unstructured":"Flori E, Doray B, Gautier E, Kohler M, Ernault P, Flori J, et al. Circulating cell-free fetal DNA in maternal serum appears to originate from cyto- and syncytio-trophoblastic cells. Case Rep Hum Reprod. 2004;19(3):723\u20134.","journal-title":"Case Rep Hum Reprod"},{"issue":"8","key":"643_CR24","doi-asserted-by":"publisher","first-page":"1218","DOI":"10.1002\/ajmg.1320470818","volume":"47","author":"LG Shaffer","year":"1993","unstructured":"Shaffer LG, McCaskill C, Haller V, Brown JA, Jackson-Cook CK. Further characterization of 19 cases of rea(21q21q) and delineation as isochromosomes or Robertsonian translocations in Down syndrome. Am J Med Genet. 1993;47(8):1218\u201322.","journal-title":"Am J Med Genet"},{"issue":"10","key":"643_CR25","doi-asserted-by":"publisher","first-page":"1490","DOI":"10.1038\/s41431-018-0188-1","volume":"26","author":"K Huijsdens-van Amsterdam","year":"2018","unstructured":"Huijsdens-van Amsterdam K, Page-Christiaens L, Flowers N, Bonifacio MD, Ellis KMB, Vogel I, et al. Isochromosome 21q is overrepresented among false-negative cell-free DNA prenatal screening results involving Down syndrome. Eur J Hum Genet. 2018;26(10):1490\u20136.","journal-title":"Eur J Hum Genet"},{"issue":"1","key":"643_CR26","doi-asserted-by":"publisher","first-page":"96","DOI":"10.1186\/s12920-020-00751-8","volume":"13","author":"HH Xu","year":"2020","unstructured":"Xu HH, Dai MZ, Wang K, Zhang Y, Pan FY, Shi WW. A rare Down syndrome foetus with de novo 21q;21q rearrangements causing false negative results in non-invasive prenatal testing: a case report. BMC Med Genom. 2020;13(1):96.","journal-title":"BMC Med Genom"}],"container-title":["Molecular Cytogenetics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13039-023-00643-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s13039-023-00643-3\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13039-023-00643-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,7,14]],"date-time":"2023-07-14T08:04:03Z","timestamp":1689321843000},"score":1,"resource":{"primary":{"URL":"https:\/\/molecularcytogenetics.biomedcentral.com\/articles\/10.1186\/s13039-023-00643-3"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,7,14]]},"references-count":26,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2023,12]]}},"alternative-id":["643"],"URL":"https:\/\/doi.org\/10.1186\/s13039-023-00643-3","relation":{},"ISSN":["1755-8166"],"issn-type":[{"value":"1755-8166","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,7,14]]},"assertion":[{"value":"7 April 2023","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"16 June 2023","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"14 July 2023","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors have no ethical conflicts to disclose, and the institutional ethics committee approved this study.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics Approval and Consent to Participate"}},{"value":"Written informed consent was obtained from the parents of the patient for publication of this case report.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for Publication"}},{"value":"The authors declare that they have no conflict of interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"16"}}